Skip to main content
. 2021 Feb 8;23(7):1139–1147. doi: 10.1093/neuonc/noab019

Table 1.

Patient Characteristics

Characteristics (n = 18)
Age (years), median (range) 55 (30–73)
Gender F/M 10/8
Patient with NF2 germline mutation 4
Patients with multiple growing locations 6
Number of growing tumors 32
KPS, n (%)
 90–100 4 (22)
 70–80 11 (61)
 <70 3 (17)
Previous surgery, n (%)
 One 2 (11)
 Multiple 16 (89)
Previous radiotherapy or radiosurgery, n (%)
 None 1 (6)
 One 8 (44)
 Multiple 9 (50)
Previous chemotherapy, n (%)
 Yes 4 (22)
 No 14 (78)
WHO grade, n (%)
 WHO grade I 1 (5%)
 WHO grade II 10 (55%)
 WHO grade III 7 (40%)

Abbreviation: KPS, Karnofsky Performance Status.